CKD 5
The percentage of patients on the CKD register with hypertension and proteinuria who are treated with an angiotensin coverting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (AEB) (unless a contraindication or side effects are recorded)
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| CKD 5 | 2011 | 164 | 187 | 87.7% | |
| CKD 5 | 2012 | 178 | 196 | 90.8% | |
| CKD 5 | 2013 | 188 | 214 | 87.8% | |
| CKD003 | 2014 | 196 | 209 | 93.8% | |
| CKD003 | 2015 | 179 | 199 | 90.0% | |
| NM84 | 2016 | 174 | 233 | 74.7% | |
| NM84 | 2018 | 208 | 293 | 71.0% | |
| NM84 | 2022 | 94 | 160 | 58.8% | |
| NM84 | 2023 | 103 | 170 | 60.6% |
